New drug designed to prevent chronic migraines

The U-S Food and Drug Administration has approved a new drug said to be the first designed to prevent chronic migraines.

Aimovig is a monthly shot developed by American drug maker Amgen and drug giant Novartis AG, and will cost almost seven-thousand dollars a year without insurance.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don’t help much or cause serious side effects.

Posted in News & Sports

+ Follow Us

 

Upcoming Events

  1. Simcoe Christmas Panorama River of Lights

    December 18 @ 4:30 pm - 11:00 pm
  2. ‘Twas the Night Before Christmas

    December 22 @ 5:00 pm - 9:00 pm
  3. Ugly Christmas Sweater Party

    December 22 @ 6:00 pm - 10:00 pm
  4. Holiday Gift Wrap Booth

    December 24 @ 9:00 am - 5:00 pm
  5. Final Destination

    December 29 @ 7:00 pm - December 30 @ 1:00 am

+ On-Air & Shows